XLE vs XLV: returns, risk and drawdowns compared
Energy Select Sector SPDR Fund against Health Care Select Sector SPDR Fund, over the same 6 years (July 2020 to October 2026) with dividends reinvested.
Data updated October 2026
XLE
Energy Select Sector SPDR Fund
10,000 became
21,305
- A year on average
- +12.7%
- Annual volatility
- 35.3%
- Deepest fall
- −57.0%
- Worst month
- −49.4%
XLV
Health Care Select Sector SPDR Fund
10,000 became
19,865
- A year on average
- +11.4%
- Annual volatility
- 14.5%
- Deepest fall
- −15.6%
- Worst month
- −8.1%
XLE came out ahead by 1.2 percentage points a year from July 2020 to October 2026. XLE swung more (35.3% against 14.5% a year). The correlation of monthly returns was 0.34: they moved together only in part.
Growth of 10,000: XLE vs XLV
Who was ahead, and when
The gap between the two over the previous three years, at each month-end. Above zero XLE had returned more, below zero XLV. XLE was ahead in 54% of the 41 three-year periods.
Annualised 3-year return of XLE minus that of XLV, in percentage points a year.
Falls from the previous high
Month-end values. Deepest fall: XLE −57.0%, XLV −15.6%.
All the figures
| XLE | XLV | |
|---|---|---|
| Annual return (CAGR) | +12.7% | +11.4% |
| Total return | +113% | +99% |
| Annual volatility | 35.3% | 14.5% |
| Deepest fall (month-end) | −57.0% | −15.6% |
| Worst month | −49.4% | −8.1% |
| Best month | +28.0% | +9.6% |
| Positive months | 57% | 59% |
| Best year | 2022: +60.9% | 2021: +26.0% |
| Worst year | 2025: −46.3% | 2022: −2.1% |
| 1-year return | +46.6% | +26.3% |
| 5 years, a year | +4.5% | +8.4% |
| 10 years, a year | +1.4% | — |
| Trading currency | USD | USD |
First nine rows: the same 76 months for both funds. Trailing returns: to each fund’s last close.
Year by year
Full calendar years both funds were trading. The higher of the two each year is in bold.
Holding both: half XLE, half XLV
| XLE alone | XLV alone | 50/50 | |
|---|---|---|---|
| A year on average | +12.7% | +11.4% | +14.0% |
| Annual volatility | 35.3% | 14.5% | 21.2% |
| Deepest fall (month-end) | −57.0% | −15.6% | −34.6% |
| Worst month | −49.4% | −8.1% | −27.5% |
Because the two did not always move together, the mix swung less than the average of the two (21.2% against 24.9%). Rebalanced to 50/50 every month, before costs.
Questions
Which has returned more, XLE or XLV?
From July 2020 to October 2026, XLE returned +12.7% a year and XLV +11.4% a year, with dividends reinvested. Over rolling 3-year periods XLE did better in 54% of cases. Past returns do not predict future returns.
Which is riskier, XLE or XLV?
Over the same months annual volatility was 35.3% for XLE and 14.5% for XLV; the deepest fall from a month-end high was 57.0% and 15.6%, and the worst single month −49.4% and −8.1%.
How correlated are XLE and XLV?
The correlation of their monthly returns was 0.34: they moved together only in part. Combining them has historically smoothed the ups and downs of either one alone.
What about holding both XLE and XLV?
Half in each, rebalanced every month, returned +14.0% a year over the same period, with 21.2% annual volatility and a deepest month-end fall of 34.6%.
More comparisons
- XLE — Energy Select Sector SPDR FundReturns, drawdowns and risk
- XLV — Health Care Select Sector SPDR FundReturns, drawdowns and risk
- XLF vs XLE
- XLE vs XLI
- XLE vs USO
- XLF vs XLV
- XLV vs XLI
- Portfolio stress test with custom shocksYour own scenarios, holding by holding
- Portfolio stress testing software comparedFeatures and prices side by side
How the figures are calculated
Total return in the fund’s trading currency, from end-of-day prices with dividends reinvested on the ex-date. The fund’s own ongoing charges are already reflected in its price; trading costs, taxes and currency conversion are not included. Past returns do not predict future returns.
The comparison uses only the months in which both funds have prices, so the figures cover the same period even when one fund is older.
Source: MarketStack end-of-day prices, total return with dividends reinvested. Figures are historical and descriptive; they are not forecasts and not investment advice. MEDGE Capital does not recommend buying or selling any instrument. Risk disclaimer.